Table 1. PET studies of dopaminergic function in non-human primates after ketamine administration compared to control.
Dopamine system studied | Study | Ketamine | Ketamine dose and route of administration | State of animal | Duration of treatment | When the outcome investigated | Ligand | Radiotracer administration | Study design/ control group | Analytical method | Region of interest | Na | Outcome measure | Change in dopamine measure after ketamine infusion compared to control condition |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dopamine synthesis | Tsukada et al.36 | Racemic | 3 and 10 mg kg−1 h−1, i.v | Anaesthetised | Infusion throughout scan | 30 mins prior to scan | L-[ β -11C]DOPA | i.v | Within/ saline | Graphical analysis (L-[ β -11C]DOPA) | Str | 4 | Dopamine synthesis rate | ↑ |
Dopamine release | Hashimoto et al., 201738 | R and S-ketamine | 0.5 mg kg−1 | Sub-anaesthetised | Infusion 40 mins | After the end of infusion | [11C]raclopride | i.v | Saline | Reference tissue model | Caudate/putamen | 4 | Δ D2/3 receptor binding potentialb | ↓29% (S-Ketamine) |
↔ No change (R Ketamine) | ||||||||||||||
Tsukada et al.36 | Racemic | 3 and 10 mg kg−1 h−1, i.v | Anaesthetised | Infusion throughout scan | 30 mins prior to scan | [11C]raclopride | i.v | Within/ saline | Kinetic analysis ([11C]raclopride) | Str | 4 | Δ Binding potentialb | ↓ | |
Dopamine transporter | Tsukada et al.36 | Racemic | 3 and 10 mg kg−1 h−1, i.v | Anaesthetised | Infusion throughout scan | 30 mins prior to scan | [11C]β-CFT | i.v | Within/ saline | Kinetic analysis ([11C]β-CFT) | Str | 4 | DAT binding potential | ↓ |
Yamamoto et al.34 | Racemic | 0.5 & 1.5 mg kg−1 | Sub-anaesthetised | Infusion 40 mins | After the end of infusion | [11C]β-CFT | Bolus i.v | Within/ saline | Reference tissue model | Ct, Str, Midbrain, Thal | 5 | DAT binding potential | ↔ No change | |
Harada et al.40 | Racemic | 3 mg kg−1 h−1 | Anaesthetised | Infusion throughout scan | 60 mins before tracers | [11C]β-CFT & [11C]β-CIT-FE | i.v | Within/ saline | Kinetic analysis | Str | 3 | DAT binding potential | ↓ ([11C]β-CFT) | |
↔ No change ([11C]β-CIT-FE) | ||||||||||||||
Tsukada et al.39 | Racemic | 3 and 10 mg kg−1 h−1, i.v | Anaesthetised | Infusion throughout scan | 60 mins before tracers | [11C]β-CFT & [11C]β-CIT-FE | i.v | Within/ saline | Kinetic analysis | Str | 5 | DAT binding potential | ↓ (3 mg kg−1) |
Abbreviations: Ct, cortex; DA, dopamine; DAT, dopamine transporter; i.m, intra muscular; i.v, intravenous; NA, not available; PET, positron emission tomography; Str, striatum; Thal, thalamus.
N the sample size represents the total number of animals used for the comparison in question.
Greater reduction in D2/D3 receptor binding potential after ketamine administration indicates greater dopamine release; ↑significant increase, ↓significant decrease and ↔no significant change.